Abstract | BACKGROUND: The estrogen-inducible pS2 gene, originally isolated from a breast cancer cell line, is correlated with hormone-dependent female breast tumors and its expression is associated with longer overall and disease-free survival. METHODS: The authors have investigated 38 samples of carcinomas of the male breast for pS2 expression by using a monoclonal antibody. The immunostaining was compared with clinical data, in particular, to the progesterone receptor status, to assess a possible prognostic value of this parameter. RESULTS: Although most cases (27 of 38) were immunopositive (i.e., above the 5th percentile of immunoreactive cells), no correlation with tumor grade and survival was notable. CONCLUSIONS: Therefore, on the contrary to the situation in female breast cancer, pS2 activity failed to constitute a new prognostic parameter in male breast carcinomas.
|
Authors | I Kardaś, G Seitz, J Limon, A Niezabitowski, J Ryś, B Theisinger, C Welter, N Blin |
Journal | Cancer
(Cancer)
Vol. 72
Issue 5
Pg. 1652-6
(Sep 01 1993)
ISSN: 0008-543X [Print] United States |
PMID | 8394203
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- Estrogens
- Neoplasm Proteins
- Proteins
- RNA, Messenger
- Receptors, Estrogen
- TFF1 protein, human
- Trefoil Factor-1
- Tumor Suppressor Proteins
|
Topics |
- Adult
- Aged
- Biomarkers, Tumor
(analysis, genetics)
- Breast Neoplasms
(genetics)
- Carcinoma
(genetics)
- Carcinoma, Intraductal, Noninfiltrating
(genetics)
- Carcinoma, Papillary
(genetics)
- Estrogens
(analysis, genetics)
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Middle Aged
- Neoplasm Proteins
(analysis, genetics)
- Oncogenes
(genetics)
- Prognosis
- Proteins
- RNA, Messenger
(genetics)
- Receptors, Estrogen
(analysis, genetics)
- Retrospective Studies
- Survival Rate
- Transcription, Genetic
- Trefoil Factor-1
- Tumor Suppressor Proteins
|